Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure

被引:63
作者
Wang, Ling Jie [2 ,3 ]
Lu, Lin [2 ,3 ]
Zhang, Feng Ru [2 ]
Chen, Qiu Jing [3 ]
De Caterina, Raffaele [1 ]
Shen, Wei Feng [2 ,3 ]
机构
[1] Univ G dAnnunzio, Univ Cardiol Dept, Osped SS Annunziata, I-66013 Chieti, Italy
[2] Shanghai Jiao Tong Univ, Sch Med, Dept Cardiol, Rui Jin Hosp, Shanghai 200025, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Inst Cardiovasc Dis, Shanghai 200025, Peoples R China
关键词
HMGB1; esRAGE; cRAGE; Chronic heart failure; Diabetes; CORONARY-ARTERY-DISEASE; END-PRODUCTS; HIGH-MOBILITY-GROUP-BOX-1; PROTEIN; HMGB1; INFLAMMATION; PROLIFERATION; DYSFUNCTION; INFARCTION; COLLAGEN; INJURY;
D O I
10.1093/eurjhf/hfq231
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims High-mobility group box-1 (HMGB1) is a ligand for the receptor for advanced glycation endproducts (RAGE). An HMGB1-RAGE interaction has been implicated in cardiac dysfunction. We assessed the association of HMGB1 and RAGE isoforms with heart failure (HF) in diabetic and non-diabetic patients. Methods and results We assayed serum levels of HMGB1, cleaved RAGE (cRAGE), endogenous secretory RAGE (esRAGE), high-sensitivity C-reactive protein (hsCRP), and N-terminal pro-brain natriuretic peptide (NT-proBNP) in parallel with assessment of left ventricular volumes and function in 125 diabetic and 222 non-diabetic Chinese patients with chronic HF. Of the total, 79 diabetic patients without HF and 220 normal subjects served as diabetic and normal controls, respectively. Serum HMGB1, cRAGE, hsCRP, and NT-proBNP levels were higher and, in contrast, esRAGE levels lower in HF patients than in subjects without HF (for all; P < 0.01), with higher levels of cRAGE and hsCRP in diabetic HF vs. non-diabetic HF patients (P < 0.01). For HF patients-with or without diabetes-HMGB1 levels correlated positively with left ventricular end-diastolic and end-systolic volumes (r = 0.267 and r = 0.321, respectively) and NT-proBNP values (r = 0.497), and were inversely related to ejection fraction (r = -0.461; all P < 0.001). Serum cRAGE levels correlated with NT-proBNP values (r = 0.451) and New York Heart Association functional class (r = 0.402; both P < 0.001). Multivariable regression analysis revealed that HMGB1, cRAGE, and esRAGE were consistently associated with HF in diabetic and non-diabetic patients. Conclusion Heart failure patients have increased serum HMGB1 and cRAGE and decreased esRAGE levels, and these are related to the severity of HF in both diabetic and non-diabetic patients. Such associations are worth further investigation.
引用
收藏
页码:440 / 449
页数:10
相关论文
共 30 条
[1]   High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes [J].
Andersson, U ;
Wang, HC ;
Palmblad, K ;
Aveberger, AC ;
Bloom, O ;
Erlandsson-Harris, H ;
Janson, A ;
Kokkola, R ;
Zhang, MH ;
Yang, H ;
Tracey, KJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (04) :565-570
[2]   High-mobility group box-1 in ischemia-reperfusion injury of the heart [J].
Andrassy, Martin ;
Volz, Hans C. ;
Igwe, John C. ;
Funke, Benjamin ;
Eichberger, Sebastian N. ;
Kaya, Ziya ;
Buss, Sebastian ;
Autschbach, Frank ;
Pleger, Sven T. ;
Lukic, Ivan K. ;
Bea, Florian ;
Hardt, Stefan E. ;
Humpert, Per M. ;
Bianchi, Marco E. ;
Mairbaeurl, Heimo ;
Nawroth, Peter P. ;
Remppis, Andrew ;
Katus, Hugo A. ;
Bierhaus, Angelika .
CIRCULATION, 2008, 117 (25) :3216-3226
[3]   Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes [J].
Aronson, D .
JOURNAL OF HYPERTENSION, 2003, 21 (01) :3-12
[4]   An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness [J].
Asif, M ;
Egan, J ;
Vasan, S ;
Jyothirmayi, GN ;
Masurekar, MR ;
Lopez, S ;
Williams, C ;
Torres, RL ;
Wagle, D ;
Ulrich, P ;
Cerami, A ;
Brines, M ;
Regan, TJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2809-2813
[5]   Effects of glucose intolerance on myocardial function and collagen-linked glycation [J].
Avendano, GF ;
Agarwal, RK ;
Bashey, RI ;
Lyons, MM ;
Soni, BJ ;
Jyothirmayi, GN ;
Regan, TJ .
DIABETES, 1999, 48 (07) :1443-1447
[6]   Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications [J].
Basta, Giuseppina .
ATHEROSCLEROSIS, 2008, 196 (01) :9-21
[7]   Tumor necrosis factor-α produced in cardiomyocytes mediates a predominant myocardial inflammatory response to stretch in early volume overload [J].
Chen, Yuanwen ;
Pat, Betty ;
Zheng, Junying ;
Cain, Laura ;
Powell, Pamela ;
Shi, Ke ;
Sabri, Abdelkarim ;
Husain, Ahsan ;
Dell'Italia, Louis J. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2010, 49 (01) :70-78
[8]   Advanced glycation end products - Sparking the development of diabetic vascular injury [J].
Goldin, Alison ;
Beckman, Joshua A. ;
Schmidt, Ann Marie ;
Creager, Mark A. .
CIRCULATION, 2006, 114 (06) :597-605
[9]   Clinical and prognostic value of advanced glycation end-products in chronic heart failure [J].
Hartog, Jasper W. L. ;
Voors, Adriaan A. ;
Schalkwijk, Casper G. ;
Scheijen, Jean ;
Smilde, Tom D. J. ;
Damman, Kevin ;
Bakker, Stephan J. L. ;
Smit, Andries J. ;
van Veldhuisen, Dirk J. .
EUROPEAN HEART JOURNAL, 2007, 28 (23) :2879-2885
[10]   Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction [J].
Hartog, Jasper W. L. ;
van de Wal, Ruud M. ;
Schalkwijk, Casper G. ;
Miyata, Toshio ;
Jaarsma, Wybren ;
Plokker, H. W. Thijs ;
van Wijk, Leen M. ;
Smit, Andries J. ;
van Veldhuisen, Dirk J. ;
Voors, Adriaan A. .
EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (04) :397-403